Word

REGENHU

Status

Registered

Status Code

700

Status Date

Tuesday, August 15, 2023

Serial Number

79322244

Registration Number

7134865

Registration Date

Tuesday, August 15, 2023

Mark Type

4000

Filing Date

Friday, April 30, 2021

Published for Opposition

Tuesday, May 30, 2023

Trademark Owner History

regenHU AG - Original Registrant

Classifications

41 Training and education services in the nature of workshops, seminars, non-downloadable webinars, and conferences in the field of bioprinting and biomanufacturing

9 laboratory apparatus and instruments, including accessories, namely, bioreactors, for cell culturing; laboratory apparatus and instruments for engineering biological tissues, tissue compositions, cell aggregates and cells, namely, laboratory apparatus and instruments for the design, engineering and maintenance of biological tissues, tissue compositions, cell aggregates and cells; laboratory robots that can be used in biotechnology and in the field of pharmaceutical and cosmetic products; 2D and 3D scanners in the field of additive manufacturing processes and applications; optical apparatus and instruments, namely, cameras, microscopes, laser measuring systems, calibration apparatus for calibrating electric microvalves, and measurement apparatus being temperature indicators, flowmeters, distance measuring apparatus, calipers, all in the field of additive manufacturing processes and applications; optical readers and optical inspection apparatus in the field of additive manufacturing processes and applications; laboratory tools and accessories for the manufacture and production of biological tissues, especially for observation, measurement, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, cameras, electric sensors, optical profilers, electrical transducers, thermal control being thermal printers, downloadable software and pre-installed software for 2D and 3D design for the definition and management of manufacturing and production processes for biological tissues or organs, medical implants and pharmaceuticals; downloadable software and pre-installed software for the operation and control of machines, instruments and apparatus intended for engineering, manufacturing and producing biological tissues, tissue compositions, cell aggregates, cells, organs, medical implants or pharmaceuticals; downloadable software and pre-installed software for the operation and control of devices being used in biotechnology and in the pharmaceutical and cosmetic industries for computer-aided three-dimensional dosing of biomaterials for biofunctional shaping of cell carrier structures, tissues, blood vessels, implants, prostheses and drug delivery systems; downloadable software and pre-installed software used for 3D design, 3D printing and 3D manufacturing; downloadable software and pre-installed software for image processing and medical image processing

7 Machines and their parts and equipment, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and producing biological tissues and organs, medical implants, pharmaceuticals; machines and instruments, namely, 3D printers, 3D bioprinters, handling apparatus for loading and unloading in the nature of loading and unloading machines, and automatic handling machine, all for manufacturing and assembling biological tissues, tissue compositions, cell aggregates and cells; additive manufacturing machines for manufacturing and producing 3D objects; extruders, namely, extruding machines for microextrusion, multi-axial extrusion, droplet extrusion, micro-fiber extrusion, patterning, mixing, combination, and 2D and 3D arrangement of liquids, biological compounds, cell solutions, hydrogels, hydrogels loaded with cells, bioceramics, bioplastics, base materials for micro and nano particles; cartridges for containing printing material for use with 3D printers, sold empty; cartridges for containing bioprinting materials for use with 3D bioprinters, sold empty; printing cartridges for containing biological materials for use with 3D printers and bioprinters, sold empty; printing cartridges for containing ink for 3D printing of biological tissues and organs; tools and accessories for manufacturing and producing biological tissues, especially for observation, measuring, handling, stimulation or modification of biological tissues, tissue compositions, cell aggregates and cells, namely, 3D printers, and thermal control being block type thermal power stations for power generation

5 ATMPs (Advanced Therapy Medicinal Products), namely, medicines for human use based on genes, tissues or cells for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological tissues, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, and gut tissues and biological organ tissue manufactured for medical and transplant purposes; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue compositions being biological tissue grafts, cell aggregates and cells intended for medical use for medical applications; medical implants comprising living bioactives, biological cells or tissues; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for medical purposes; biological preparations for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries and biological tissue cultures for veterinary purposes; pharmaceutical products for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; tissue-regenerative pharmaceutical preparations for prevention and treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; medicines and gel capsules for medical use for the treatment of cancer, degenerative diseases, bacterial infections, viral infections, autoimmune diseases, and traumatic injuries; biological implants for surgical and orthopedic purposes, namely, bone, cartilage, skin, blood vessel, neural, muscular, heart, adipose, ocular, liver, pancreatic, gut, and biological organ tissue intended for subsequent implantation

1 Chemical, biochemical and biological products, namely, unprocessed natural and synthetic polymers, hydrogels being cellulose for industrial purposes and collagen for industrial purposes, weak and strong gels being Polyethylene glycol, synthetic unprocessed resins, pastes being silicone fluids, degreasing solvents, liquid carriers being cell culture media, chemical additives improving ink printability, plasticizers, biochemicals, unprocessed growth factors, thermoplastic polymers, chemical composites, metallic and ceramic micro and nanoparticles being calcium phosphates, graphene, iron oxide, and silica particles, biological molecules being enzymes and peptides, active pharmaceutical ingredients and cell culture media for laboratory use, all for use in the manufacture and production of biological tissues; ink for 3D printing of biological tissues and organs; biologically compatible materials, namely, hydrogels used to create structures and scaffolds used in the manufacture and production of biological tissues; biologically compatible materials, namely, hydrogels used to create polymer arrays for scientific and medical research used in the manufacture and production of biological tissues; cell culture media, reagents for scientific or medical research use for use with biological tissues, tissue arrays, cell aggregates and cells; biological tissue samples being biological tissue cultures, biological tissue-engineered tissues being biological tissue cultures, tissue arrays, cell aggregates and cells for scientific research purpose; liquid photosensitive chemicals and resin products, namely, photoinitiators for use in the manufacture of 3D objects; solid imaging materials used to create 3D objects, namely, photocurable unprocessed polymers, unprocessed powder polymers and plastic molding compounds used in the manufacture of 3D objects; unprocessed polymers and unprocessed artificial resins for additive manufacturing of crowns, being dental inlays and onlays, and dental implants

10 Non-biological implants being surgical implant comprised of artificial materials produced by additive manufacturing intended for surgical and orthopedic purposes; dental crowns, incrustations being dental inlays and onlays and dental implants made by additive manufacturing; artificial implants and transplants being implants comprising natural, non-living material intended for replacing and/or supporting the function of missing or damaged body parts; surgical apparatus and instruments involving the extrusion, dosing or manufacture of biological tissues, tissue arrays, cell aggregates and cells, namely, surgical robots and surgical instruments; surgical and medical devices for use in situ bioprinting, namely, surgical robots and surgical instruments

42 Scientific services, namely, conducting technical project studies in the nature of conducting scientific feasibility studies in the field of additive manufacturing, technological research in the field of additive manufacturing, research and development of new products for others in the field of additive manufacturing; research and development in the field of additive manufacturing; scientific services in connection with the design, development and support of software, namely, conducting technical project studies in the nature of conducting scientific feasibility studies, computer software consultancy, computer software design, research and development of new products for others; advice and information concerning additive manufacturing research and development and software design and development

Trademark Events

Nov 15, 2023

Final Disposition Notice Sent To Ib

Nov 15, 2023

Final Disposition Processed

Nov 15, 2023

Final Disposition Notice Created, To Be Sent To Ib

Aug 15, 2023

Notice Of Registration Confirmation Emailed

Aug 15, 2023

Registered-Principal Register

May 30, 2023

Notification Processed By Ib

May 30, 2023

Official Gazette Publication Confirmation E-Mailed

May 30, 2023

Published For Opposition

May 10, 2023

Notification Of Possible Opposition Sent To Ib

May 10, 2023

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 10, 2023

Notification Of Notice Of Publication E-Mailed

Apr 26, 2023

Approved For Pub - Principal Register

Apr 25, 2023

Examiner's Amendment Entered

Apr 25, 2023

Notification Of Examiners Amendment E-Mailed

Apr 25, 2023

Examiners Amendment E-Mailed

Apr 25, 2023

Examiners Amendment -Written

Mar 29, 2023

Notification Of Possible Opposition - Processed By Ib

Mar 8, 2023

Notification Of Possible Opposition Sent To Ib

Mar 8, 2023

Teas/Email Correspondence Entered

Mar 8, 2023

Correspondence Received In Law Office

Mar 8, 2023

Teas Request For Reconsideration Received

Mar 8, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Dec 18, 2022

New Representative At Ib Received

Sep 8, 2022

Notification Of Final Refusal Emailed

Sep 8, 2022

Final Refusal E-Mailed

Sep 8, 2022

Final Refusal Written

Aug 3, 2022

Teas/Email Correspondence Entered

Aug 2, 2022

Correspondence Received In Law Office

Aug 2, 2022

Teas Response To Office Action Received

Jun 10, 2022

New Representative At Ib Received

Feb 20, 2022

Refusal Processed By Ib

Feb 2, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Feb 2, 2022

Refusal Processed By Mpu

Jan 12, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Jan 11, 2022

Non-Final Action Written

Jan 3, 2022

Assigned To Examiner

Oct 16, 2021

Application Filing Receipt Mailed

Oct 12, 2021

New Application Office Supplied Data Entered

Oct 8, 2021

Sn Assigned For Sect 66a Appl From Ib